हिंदी खबर
Dr Bharati Pravin Pawar chairs Azadi ka Amrit Mahotsav - 30-year celebration of National Institute of Biologicals. (Photo/PIB)
Dr Bharati Pravin Pawar chairs Azadi ka Amrit Mahotsav - 30-year celebration of National Institute of Biologicals. (Photo/PIB)

Biologicals emerged as therapy of choice where traditional chemical drugs fail: Dr Bharati Pravin Pawar

ANI | Updated: Jun 30, 2022 22:02 IST

New Delhi [India], June 30 (ANI): Union Minister of State, Dr Bharati Pravin Pawar on Thursday chaired Azadi ka Amrit Mahotsav - a 30-year celebration of the National Institute of Biologicals (NIB) in Noida.
Rajesh Bhushan, Secretary, Ministry of Health and Family Welfare, Dr Balram Bhargava, DG, ICMR and Dr Anup Anvikar, Director, National Institute of Biologicals were also present at the event.
Accentuating the contribution of NIB not only in terms of repository of wisdom, knowledge, experience and expertise but in the growth of our nation also, Dr Bharati Pravin Pawar said, "The consistent efforts in promoting public health, by weeding out "Sub Standard Quality" products from entering the market and developing standards for assuring quality, the institute deserves great applause. But yet the challenges are far from over."
"We all are aware that substandard or spurious drugs are a global problem with respect to Health and Economic burden. Biologicals have emerged as a therapy of choice where traditional chemical drugs fail to serve the purpose. Hence, Quality testing plays a pivotal role to stop substandard biologicals from reaching the patient and adversely affecting the health," Pawar said.
She further added that with its cutting-edge infrastructure, which has facilitated the pathway to unmatched excellence, NIB has been successful in maintaining the impeccable standards for its lab and animal housing facilities.

The recommendations for those biological products that were found to be NSQ (Not of Standard Quality) for release in the market are very crucial, as it is directly linked with patient safety and safeguarding public health, she said.
"NIB gives priority to Government medical supplies and procurement agencies so that there is no shortage of life-saving drugs in the Indian market. I believe this vigilance and this expertise in the field are much needed in the sensitive sector as it is where there is the direct involvement of human lives. NIB has also provided very strong support to the National Regulatory Authorities for keeping a close check on the quality of the biologicals being manufactured indigenously or imported into the country," she noted.
Highlighting the efforts of the government, Union Minister of State said, "Under the dynamic leadership of Prime Minister Narendra Modi, we are on the path of becoming "Pharmacy of the World". It is all because of the goodwill that the pharmaceutical sector has earned all across the globe."
"It becomes more of our duty to maintain the best quality of the drugs and also to keep it affordable for the masses so that it is accessible to the poorest of poor. It is the path towards realising the vision of our Prime Minister to achieve "Health for all". Our Prime Minister has always believed in helping other nations even during the COVID pandemic too," she added.
Pawar said that India has been leading the world in the pharma industry but still, I would suggest that NIB should undertake the testing of more biologicals and also extend its testing expertise in helping other countries following the "Vasudhaiva Kutumbakam" philosophy of Indian ethos.
Union Minister of State also visited state-of-art laboratory facilities at the NIB and felicitated 28 NIB employees for their contribution to the institute over 25 years.
Further, she requested senior officials of NIB to explore more opportunities for collaboration with other National and International Scientific Institutions and organizations in upgrading technologies and keeping abreast of scientific advances made in the field of quality assessment of Biological and Biotherapeutic products. (ANI)